Cochlear Ltd Unsponsored ADR (CHEOY)
Cochlear Limited (CHEOY) Q3 2026 Sales/Trading Call Transcript
Cochlear Limited (CHEOY) Q3 2026 Sales/Trading Call Transcript
Australia's Cochlear crashes 40% after flagging weak demand and Mideast war impact
Cochlear shares crashed nearly 41% on Wednesday in a record daily fall, after the Australian hearing implants maker slashed its forecast for annual earnings, citing weak trading conditions and uncertainty stoked by the Middle East war.
Cochlear Limited (CHEOY) Q2 2026 Earnings Call Transcript
Cochlear Limited (CHEOY) Q2 2026 Earnings Call Transcript
Cochlear Limited (CHEOF) Q4 2025 Earnings Call Transcript
Cochlear Limited (OTCPK:CHEOF) Q4 2025 Earnings Conference Call August 14, 2025 8:00 PM ET Company Participants Diggory William Howitt - CEO, MD, President & Executive Director Sarah Thom - Chief Financial Officer Conference Call Participants Andrew Goodsall - MST Financial Services Pty Limited, Research Division Andrew Paine - CLSA Limited, Research Division Christine Trinh - Macquarie Research Craig Wong-Pan - RBC Capital Markets, Research Division David A. Low - JPMorgan Chase & Co, Research Division David Andrew Stanton - Jefferies LLC, Research Division David Bailey - Unidentified Company Morgan Stanley - Unidentified Company Davinthra Thillainathan - Goldman Sachs Group, Inc., Research Division Lyanne Harrison - BofA Securities, Research Division Marcus Curley - UBS Investment Bank, Research Division Sacha Krien - Unidentified Company Evanson Partners - Unidentified Company Saul Hadassin - Barrenjoey Markets Pty Limited, Research Division Steven David Wheen - Jarden Limited, Research Division Operator Thank you for standing by, and welcome to the Cochlear Limited FY '25 Results Analyst and Media Briefing.
Cochlear downgrades FY25 earnings guidance, unveils smart cochlear implant system
Cochlear Ltd has lowered its earnings guidance amid slower-than-expected sales growth, just as it unveils the Nucleus Nexa System, its world-first smart cochlear implant with upgradeable firmware. While the guidance revision initially sent shares down by nearly 9%, the stock has since rebounded, as investors weigh the potential of the new technology alongside the company's updated financial outlook.
Cochlear CEO on tariffs: 'Watch and wait' to see what happens
Dig Howitt, CEO and President of Cochlear, discusses the company's half-year earnings, potential impact of tariffs on the business, and the plunge in the company's share price.
Australia's Cochlear faces worst day in 5 years on weak earnings, forecast
Cochlear shares were on track for their worst session in five years on Friday, after the Australian hearing implants maker reported first-half profit below estimates and forecast annual earnings at the lower end of its previous range.
Cochlear Limited (CHEOF) Q2 2025 Earnings Call Transcript
Cochlear Limited (OTCPK:CHEOF) Q2 2025 Earnings Conference Call February 13, 2025 6:00 PM ET Company Participants Dig Howitt - President & Chief Executive Officer Stu Sayers - President of Asia Pacific & Latin America Conference Call Participants Andrew Goodsall - MST Marquee David Low - JPMorgan Saul Hadassin - Barrenjoey David Stanton - Jefferies Steve Wheen - Jarden Davin Thillainathan - Goldman Sachs Mathieu Chevrier - Citi Craig Wong-Pan - RBC Laura Sutcliffe - UBS Lyanne Harrison - Bank of America Operator Thank you for standing by, and welcome to the Cochlear Limited Half Year 2025 Results Analyst and Media Briefing. All participants are in listen-only mode.
Cochlear Limited (CHEOF) Q4 2024 Earnings Call Transcript
Cochlear Limited (OTCPK:CHEOF) Q4 2024 Earnings Conference Call August 14, 2024 8:00 PM ET Company Participants Dig Howitt - President and CEO Stu Sayers - Chief Financial Officer Conference Call Participants Andrew Goodsall - MST David Low - JPMorgan Saul Hadassin - Barrenjoey Steve Wheen - Jarden David Stanton - Jefferies Gretel Janu - E&P David Bailey - Macquarie Andrew Paine - CLSA Shane Storey - Wilsons Advisory Craig Wong-Pan - RBC Lyanne Harrison - BofA Mathieu Chevrier - Citi Laura Sutcliffe - UBS Operator Thank you for standing by. And welcome to the Cochlear Limited FY 2024 Results, Analyst and Media Briefing.
What Makes CochLear Ltd. Unsponsored ADR (CHEOY) a New Buy Stock
CochLear Ltd. Unsponsored ADR (CHEOY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects.
Australia, Cochlear support Japan programme for child hearing implants
Hearing impaired children in Japan's coastal city of Shizuoka will from next year be able to listen, learn and speak better thanks to an A$6.5 million ($4.4 million) programme funded by the city and the government of Australia.
